AU2002232078A1 - Clostridium difficile vaccine - Google Patents

Clostridium difficile vaccine

Info

Publication number
AU2002232078A1
AU2002232078A1 AU2002232078A AU2002232078A AU2002232078A1 AU 2002232078 A1 AU2002232078 A1 AU 2002232078A1 AU 2002232078 A AU2002232078 A AU 2002232078A AU 2002232078 A AU2002232078 A AU 2002232078A AU 2002232078 A1 AU2002232078 A1 AU 2002232078A1
Authority
AU
Australia
Prior art keywords
clostridium difficile
difficile vaccine
vaccine
clostridium
difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002232078A
Inventor
Ni Eidhin Deirdre
Rachael Doyle
Dermot Kelleher
James Bernard Walsh
Henry J. Windle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Original Assignee
College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin filed Critical College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin
Publication of AU2002232078A1 publication Critical patent/AU2002232078A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002232078A 2001-02-09 2002-02-11 Clostridium difficile vaccine Abandoned AU2002232078A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE2001/0137 2001-02-09
IE20010137 2001-02-09
PCT/IE2002/000017 WO2002062379A2 (en) 2001-02-09 2002-02-11 Clostridium difficile vaccine

Publications (1)

Publication Number Publication Date
AU2002232078A1 true AU2002232078A1 (en) 2002-08-19

Family

ID=11042737

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002232078A Abandoned AU2002232078A1 (en) 2001-02-09 2002-02-11 Clostridium difficile vaccine

Country Status (4)

Country Link
US (2) US20030054009A1 (en)
EP (1) EP1358331A2 (en)
AU (1) AU2002232078A1 (en)
WO (1) WO2002062379A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0309126D0 (en) 2003-04-17 2003-05-28 Neutec Pharma Plc Clostridium difficile focussed antibodies
GB0414886D0 (en) 2004-07-02 2004-08-04 Neutec Pharma Plc Treatment of bacterial infections
GB201016742D0 (en) 2010-10-05 2010-11-17 Health Prot Agency Clostridium difficile antigens
WO2013071409A1 (en) 2011-11-18 2013-05-23 National Research Council Of Canada (Nrc) Clostridium difficile lipoteichoic acid and uses thereof
CA3238720A1 (en) 2021-12-02 2023-06-08 Sandra Wingaard Thrane Single domain antibodies for prevention of clostridium difficile infection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601823A (en) * 1989-10-31 1997-02-11 Ophidian Pharmaceuticals, Inc. Avian antitoxins to clostridium difficle toxin A
US5849874A (en) * 1991-07-12 1998-12-15 Gist-Brocades, N.V. Process for the purification of serum albumin
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
US5872238A (en) * 1994-06-24 1999-02-16 Thermogen, Inc. Thermophile gene transfer
CA2197714A1 (en) * 1994-09-06 1996-03-14 Immucell Corporation Therapeutic treatment of clostridium difficile associated diseases
DE19603649A1 (en) * 1996-02-01 1997-08-07 Werner Lubitz Recombinant expression of S-layer proteins
US5965375A (en) * 1997-04-04 1999-10-12 Biosite Diagnostics Diagnostic tests and kits for Clostridium difficile
DE19739685A1 (en) * 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
AU754270B2 (en) * 1997-10-20 2002-11-07 Sanofi Pasteur Biologics, Llc Passive immunization against clostridium difficile disease
US20020009429A1 (en) * 1999-01-29 2002-01-24 Galagen, Inc. Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
GB0007263D0 (en) * 2000-03-24 2000-05-17 Imperial College Peptides
US20030186340A1 (en) * 2000-04-17 2003-10-02 Myong-Joon Hahn Epitope tag recognized by a monoclonal antibody to Rickettsia typhi

Also Published As

Publication number Publication date
WO2002062379A3 (en) 2003-01-16
WO2002062379A2 (en) 2002-08-15
US20070065466A1 (en) 2007-03-22
EP1358331A2 (en) 2003-11-05
US20030054009A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
AU2002236159A1 (en) Immunogenic complex
AUPR459901A0 (en) Instant messaging
AU2002315779A1 (en) Soft capsules
AU2002317568A1 (en) Technical field
AU2002254558A1 (en) Novel vaccine
AU2002360455A1 (en) Restricted getter
AU2002366513A1 (en) Scoring methodology
AU2003285320A1 (en) Vaccine
AU2002232078A1 (en) Clostridium difficile vaccine
AU2002236160A1 (en) Immunogenic complex comprising ribosomes
AU2002254161A1 (en) M cell directed vaccines
AU2002330627A1 (en) Corkscrew
AU2002304165A1 (en) Polynucleotide vaccine
AU2002303093A1 (en) Mycobacterial vaccines
AU2001100406A4 (en) DriverSMS
AUPR282101A0 (en) Juvenile hormone esterase
AUPR909301A0 (en) Flavivirus vaccine system
AU2002337263A1 (en) Anti-coronavirus vaccine
AUPR440001A0 (en) Vaccine
AU2002302785A1 (en) Vaccines
AU2002253048A1 (en) Novel vaccine
AU2002950974A0 (en) Flavivirus vaccine system
AUPR600001A0 (en) Follow me software
AU2002100681A4 (en) Improved rotating-wing aircraft
AU2002311405A1 (en) Vaccine composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase